https://projects.propublica.org/d4d-archive/companies/johnso...
How is this legal? I'm ignorant of the details but for instance, if you click on California and look at Speaking, top of the list doc got $86,550!
https://projects.propublica.org/d4d-archive/companies/johnso...
How is this legal? I'm ignorant of the details but for instance, if you click on California and look at Speaking, top of the list doc got $86,550!
This is again, not necessarily evil -- in fact, it's a logical continuation of the law which mandates that companies only promote their drugs exactly and only for what FDA regulations approved the drugs for. The problem, as presented in the OP, is when doctors unofficially (i.e personally) endorse/promote/heavily prescribe drugs for off-label uses. Again, not an illegal thing on its own, as doctors are trusted to prescribe what a patient needs based on their professional judgment (or else, Dr. "House, M.D." would be in prison)...but the worry is that a financial relationship with a company (i.e. the payments for touting the official line) have the potential to taint a doctor's professional judgment.
[disclosure: I used to work at ProPublica and on the Dollars for Docs project]
[1] http://www.propublica.org/article/double-dip-doctors-paid-to...
When I get a prescription from a doctor I have no idea whether or not he is getting something out of it. Whether it be speaking fees, a new pen, lunches, or whatever. Legal or not. I just trust that that doc is acting in my best interest.
And thank you for the work on the Dollars for Docs project. I for one am appreciative of this find.
I believe that in places with centralized healthcare systems, there are people who are responsible to understand the new drugs, both at the level of the healthcare provider and the health ministry - and they guide doctors on what to prescribe.
This makes sense because they don't have a conflict of interest(unless bribed).
"The government investigation of Risperdal sales later unearthed one email from a Johnson & Johnson salesperson that was typical of the approach. She told her supervisor that she was going to promise one doctor that if he raised his Risperdal market share from 16 percent to 50 percent in the coming 12 months he could become a paid speaker."